These proteases not only degrade the extracellular matrix to facilitate tumor invasion but can also cleave immune checkpoint molecules (such as PD-L1, programmed death ligand 1) or chemokines (such as CXCL10, c-x-c motif chemokine ligand 10) in the TME (52, 53). This evidence concerns the gene CXCL10 and neoplasm.